Skip to main content
Erschienen in: European Journal of Pediatrics 8/2021

04.06.2021 | Original Article

Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country

verfasst von: Mohd Nizam Mat Bah, Emieliyuza Yusnita Alias, Hasliza Razak, Mohd Hanafi Sapian, Fang Han Foo, Nisah Abdullah

Erschienen in: European Journal of Pediatrics | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Data on Kawasaki disease from tropical countries are scarce. Hence, this population-based study aims to determine the epidemiology, clinical characteristics, and outcome of Kawasaki disease in children enrolled in the Kawasaki disease registry between 2006 and 2019 in Southern Malaysia. Diagnosis of Kawasaki disease was made using standard criteria. Primary outcome measure was a coronary artery aneurysm. Multivariable logistic regression was used to analyze the associated risk factors for coronary artery aneurysm. There were 661 Kawasaki disease, with 27% incomplete and 11% atypical presentations. Male-to-female ratio was 2:1, and median age of diagnosis was 1.4 years (interquartile range 9 to 32 months). Incidence in children of less than 5 years was 14.8 (95% confidence interval [CI]: 13.6 to 16.0) per 100,000 population, higher in males (19/100,000) and Chinese (22/100,000), with a gradual increase from 5.7/100,000 in 2006 to 19.6/100,000 in 2019, p < 0.001. Incidence in children between 5 and 9 years old was 1.3 (95% CI: 0.9 to 1.6) per 100,000 population and remained stable over time. There was a seasonal pattern with peak incidence during the rainy season. Out of 625 intravenous immunoglobulins (IVIG)-treated Kawasaki disease, 7.4% were resistant, and 9% had coronary artery aneurysms. Atypical presentation, male sex, late diagnosis, and IVIG resistance were independent risk factors for coronary artery aneurysms.
Conclusions: Despite the tropical climate, Kawasaki disease epidemiology is similar to non-tropic regions with seasonal patterns and a rising incidence. Atypical presentation, male sex, late diagnosis, and IVIG resistance were significantly associated with coronary artery aneurysms.
What is Known:
• Kawasaki disease predominantly occurs in males, children less than 5 years old, and the Asian population.
• Male sex, late diagnosis, incomplete Kawasaki disease, and IVIG resistance were associated with coronary artery aneurysms.
What is New:
• In multi-ethnic Asian countries such as Malaysia, ethnic Chinese have a higher prevalence of Kawasaki disease compared to other ethnicities.
• Kawasaki disease with atypical presentation can occur in both complete and incomplete Kawasaki disease and is significantly associated with a coronary artery aneurysm.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 114:1708–1733CrossRef Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 114:1708–1733CrossRef
2.
Zurück zum Zitat Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, Turner CL (2000) Kawasaki disease: a brief history. Pediatrics 106:1–8CrossRef Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, Turner CL (2000) Kawasaki disease: a brief history. Pediatrics 106:1–8CrossRef
3.
Zurück zum Zitat McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999CrossRef McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999CrossRef
4.
Zurück zum Zitat Barone SR, Pontrelli LR, Krilov LR (2000) The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med 154:453–456CrossRef Barone SR, Pontrelli LR, Krilov LR (2000) The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med 154:453–456CrossRef
5.
Zurück zum Zitat Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RSM (2012) Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 171:657–662CrossRef Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RSM (2012) Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 171:657–662CrossRef
6.
Zurück zum Zitat Falcini F, Ozen S, Magni-Manzoni S, Candelli M, Ricci L, Martini G, Cuttica RJ, Oliveira S, Calabri GB, Zulian F, Pistorio A, la Torre F, Rigante D (2012) Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based survey. Clin Exp Rheumatol 30:799–804PubMed Falcini F, Ozen S, Magni-Manzoni S, Candelli M, Ricci L, Martini G, Cuttica RJ, Oliveira S, Calabri GB, Zulian F, Pistorio A, la Torre F, Rigante D (2012) Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based survey. Clin Exp Rheumatol 30:799–804PubMed
7.
Zurück zum Zitat Tulloh RMR, Mayon-White R, Harnden A, Ramanan AV, Tizard EJ, Shingadia D, Michie CA, Lynn RM, Levin M, Franklin OD, Craggs P, Davidson S, Stirzaker R, Danson M, Brogan PA (2019) Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015. Arch Dis Child 104:640–646CrossRef Tulloh RMR, Mayon-White R, Harnden A, Ramanan AV, Tizard EJ, Shingadia D, Michie CA, Lynn RM, Levin M, Franklin OD, Craggs P, Davidson S, Stirzaker R, Danson M, Brogan PA (2019) Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015. Arch Dis Child 104:640–646CrossRef
8.
Zurück zum Zitat Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, Yashiro M, Nakamura Y, Yanagawa H (2007) Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 49:421–426CrossRef Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, Yashiro M, Nakamura Y, Yanagawa H (2007) Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 49:421–426CrossRef
9.
Zurück zum Zitat Xie L, Yan W, Huang M, Huang M, Chen S, Huang G, Liu F (2020) Epidemiologic features of Kawasaki disease in Shanghai from 2013 through 2017. J Epidemiol 30:429–435CrossRef Xie L, Yan W, Huang M, Huang M, Chen S, Huang G, Liu F (2020) Epidemiologic features of Kawasaki disease in Shanghai from 2013 through 2017. J Epidemiol 30:429–435CrossRef
10.
Zurück zum Zitat Fernandez-Cooke E, Tascón AB, Sánchez-Manubens J et al (2019) Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011- 2016): KAWA-RACE study group. PLoS One 14:1–18 Fernandez-Cooke E, Tascón AB, Sánchez-Manubens J et al (2019) Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011- 2016): KAWA-RACE study group. PLoS One 14:1–18
11.
Zurück zum Zitat Manlhiot C, O’Shea S, Bernknopf B et al (2018) Epidemiology of Kawasaki disease in Canada 2004 to 2014: comparison of surveillance using administrative data vs periodic medical record review. Can J Cardiol 34:303–309CrossRef Manlhiot C, O’Shea S, Bernknopf B et al (2018) Epidemiology of Kawasaki disease in Canada 2004 to 2014: comparison of surveillance using administrative data vs periodic medical record review. Can J Cardiol 34:303–309CrossRef
12.
Zurück zum Zitat Rowley AH (2011) Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med 62:69–77CrossRef Rowley AH (2011) Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med 62:69–77CrossRef
13.
Zurück zum Zitat Burns JC, Herzog L, Fabri O et al (2013) Seasonality of Kawasaki disease: a global perspective. PLoS One 8:1–11 Burns JC, Herzog L, Fabri O et al (2013) Seasonality of Kawasaki disease: a global perspective. PLoS One 8:1–11
14.
Zurück zum Zitat Onouchi Y (2018) The genetics of Kawasaki disease. Int J Rheum Dis 21:26–30CrossRef Onouchi Y (2018) The genetics of Kawasaki disease. Int J Rheum Dis 21:26–30CrossRef
15.
Zurück zum Zitat Kwon YC, Kim JJ, Yun SW et al. (2017) Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease. PLoS One 12:1-11. Kwon YC, Kim JJ, Yun SW et al. (2017) Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease. PLoS One 12:1-11.
16.
Zurück zum Zitat Lin L, Wang SY, Yang SB, Xiao FC (2015) Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease: a meta-analysis. Genet Mol Res 14:6256–6264CrossRef Lin L, Wang SY, Yang SB, Xiao FC (2015) Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease: a meta-analysis. Genet Mol Res 14:6256–6264CrossRef
17.
Zurück zum Zitat Menikou S, Langford PR, Levin M (2019) Kawasaki disease: the role of immune complexes revisited. Front Immunol 10:1156CrossRef Menikou S, Langford PR, Levin M (2019) Kawasaki disease: the role of immune complexes revisited. Front Immunol 10:1156CrossRef
18.
Zurück zum Zitat Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y (2015) Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease. Circ J 79:1349–1356CrossRef Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y (2015) Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease. Circ J 79:1349–1356CrossRef
19.
Zurück zum Zitat Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, Aoyama Y, Yanagawa H (2019) Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015–2016. Pediatr Int 61:397–403CrossRef Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, Aoyama Y, Yanagawa H (2019) Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015–2016. Pediatr Int 61:397–403CrossRef
20.
Zurück zum Zitat Ha S, Seo GH, Kim KY, Kim DS (2016) Epidemiologic study on kawasaki disease in Korea, 2007-2014: based on health insurance review & assessment service claims. J Korean Med Sci 31:1445–1449CrossRef Ha S, Seo GH, Kim KY, Kim DS (2016) Epidemiologic study on kawasaki disease in Korea, 2007-2014: based on health insurance review & assessment service claims. J Korean Med Sci 31:1445–1449CrossRef
21.
Zurück zum Zitat Huang YH, Lin KM, Ho SC, Yan JH, Lo MH, Kuo HC (2019) Increased incidence of Kawasaki disease in Taiwan in recent years: a 15 years nationwide population-based cohort study. Front Pediatr 7:121CrossRef Huang YH, Lin KM, Ho SC, Yan JH, Lo MH, Kuo HC (2019) Increased incidence of Kawasaki disease in Taiwan in recent years: a 15 years nationwide population-based cohort study. Front Pediatr 7:121CrossRef
22.
Zurück zum Zitat Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 29:483–488CrossRef Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 29:483–488CrossRef
23.
Zurück zum Zitat Mauro A, Fabi M, Da Frè M, Guastaroba P, Corinaldesi E, Calabri GB, Giani T, Simonini G, Rusconi F, Cimaz R (2016) Kawasaki disease: an epidemiological study in central Italy. Pediatr Rheumatol 14:1–6CrossRef Mauro A, Fabi M, Da Frè M, Guastaroba P, Corinaldesi E, Calabri GB, Giani T, Simonini G, Rusconi F, Cimaz R (2016) Kawasaki disease: an epidemiological study in central Italy. Pediatr Rheumatol 14:1–6CrossRef
24.
Zurück zum Zitat Durongpisitkul K, Sangtawesin C, Khongphatthanayopthin A, Panamonta M, Sopontammarak S, Sittiwangkul R, Pongpanich B (2006) Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand. Asian Pac J Allergy Immunol 24:27–32PubMed Durongpisitkul K, Sangtawesin C, Khongphatthanayopthin A, Panamonta M, Sopontammarak S, Sittiwangkul R, Pongpanich B (2006) Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand. Asian Pac J Allergy Immunol 24:27–32PubMed
25.
Zurück zum Zitat Mohtar ZA, Yahaya AS, Ahmad F, Suri S, Halim MH (2014) Trends for daily rainfall in northern and southern region of Peninsular Malaysia. J Civ Eng Res 4:222–227 Mohtar ZA, Yahaya AS, Ahmad F, Suri S, Halim MH (2014) Trends for daily rainfall in northern and southern region of Peninsular Malaysia. J Civ Eng Res 4:222–227
26.
Zurück zum Zitat Suzuki T, Michihata N, Yoshikawa T, Hata T, Matsui H, Fushimi K, Yasunaga H (2020) High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more. Eur J Pediatr 179(12):1901–1907CrossRef Suzuki T, Michihata N, Yoshikawa T, Hata T, Matsui H, Fushimi K, Yasunaga H (2020) High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more. Eur J Pediatr 179(12):1901–1907CrossRef
27.
Zurück zum Zitat Fu PP, Du ZD, Pan YS (2013) Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease. Pediatr Infect Dis J 32:e319–e323CrossRef Fu PP, Du ZD, Pan YS (2013) Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease. Pediatr Infect Dis J 32:e319–e323CrossRef
28.
Zurück zum Zitat Kim GB (2019) Reality of kawasaki disease epidemiology. Korean J Pediatr 62:292–296CrossRef Kim GB (2019) Reality of kawasaki disease epidemiology. Korean J Pediatr 62:292–296CrossRef
29.
Zurück zum Zitat Singh S, Bhattad S (2016) Kawasaki disease incidence at Chandigarh, North India, during 2009–2014. Rheumatol Int 36:1391–1397CrossRef Singh S, Bhattad S (2016) Kawasaki disease incidence at Chandigarh, North India, during 2009–2014. Rheumatol Int 36:1391–1397CrossRef
31.
Zurück zum Zitat Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, Moore DP, Nunes M, Rath B, Campbell H, Nair H, Acacio S, Alonso WJ, Antonio M, Ayora Talavera G, Badarch D, Baillie VL, Barrera-Badillo G, Bigogo G, Broor S, Bruden D, Buchy P, Byass P, Chipeta J, Clara W, Dang DA, de Freitas Lázaro Emediato CC, de Jong M, Díaz-Quiñonez JA, Do LAH, Fasce RA, Feng L, Ferson MJ, Gentile A, Gessner BD, Goswami D, Goyet S, Grijalva CG, Halasa N, Hellferscee O, Hessong D, Homaira N, Jara J, Kahn K, Khuri-Bulos N, Kotloff KL, Lanata CF, Lopez O, Lopez Bolaños MR, Lucero MG, Lucion F, Lupisan SP, Madhi SA, Mekgoe O, Moraleda C, Moyes J, Mulholland K, Munywoki PK, Naby F, Nguyen TH, Nicol MP, Nokes DJ, Noyola DE, Onozuka D, Palani N, Poovorawan Y, Rahman M, Ramaekers K, Romero C, Schlaudecker EP, Schweiger B, Seidenberg P, Simoes EAF, Singleton R, Sistla S, Sturm-Ramirez K, Suntronwong N, Sutanto A, Tapia MD, Thamthitiwat S, Thongpan I, Tillekeratne G, Tinoco YO, Treurnicht FK, Turner C, Turner P, van Doorn R, van Ranst M, Visseaux B, Waicharoen S, Wang J, Yoshida LM, Zar HJ (2019) Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health 7:e1031–e1045CrossRef Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, Moore DP, Nunes M, Rath B, Campbell H, Nair H, Acacio S, Alonso WJ, Antonio M, Ayora Talavera G, Badarch D, Baillie VL, Barrera-Badillo G, Bigogo G, Broor S, Bruden D, Buchy P, Byass P, Chipeta J, Clara W, Dang DA, de Freitas Lázaro Emediato CC, de Jong M, Díaz-Quiñonez JA, Do LAH, Fasce RA, Feng L, Ferson MJ, Gentile A, Gessner BD, Goswami D, Goyet S, Grijalva CG, Halasa N, Hellferscee O, Hessong D, Homaira N, Jara J, Kahn K, Khuri-Bulos N, Kotloff KL, Lanata CF, Lopez O, Lopez Bolaños MR, Lucero MG, Lucion F, Lupisan SP, Madhi SA, Mekgoe O, Moraleda C, Moyes J, Mulholland K, Munywoki PK, Naby F, Nguyen TH, Nicol MP, Nokes DJ, Noyola DE, Onozuka D, Palani N, Poovorawan Y, Rahman M, Ramaekers K, Romero C, Schlaudecker EP, Schweiger B, Seidenberg P, Simoes EAF, Singleton R, Sistla S, Sturm-Ramirez K, Suntronwong N, Sutanto A, Tapia MD, Thamthitiwat S, Thongpan I, Tillekeratne G, Tinoco YO, Treurnicht FK, Turner C, Turner P, van Doorn R, van Ranst M, Visseaux B, Waicharoen S, Wang J, Yoshida LM, Zar HJ (2019) Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health 7:e1031–e1045CrossRef
32.
Zurück zum Zitat Saundankar J, Yim D, Itotoh B, Payne R, Maslin K, Jape G, Ramsay J, Kothari D, Cheng A, Burgner D (2014) The epidemiology and clinical features of kawasaki disease in Australia. Pediatrics 133:e1009–e1014CrossRef Saundankar J, Yim D, Itotoh B, Payne R, Maslin K, Jape G, Ramsay J, Kothari D, Cheng A, Burgner D (2014) The epidemiology and clinical features of kawasaki disease in Australia. Pediatrics 133:e1009–e1014CrossRef
33.
Zurück zum Zitat Friedman KG, Gauvreau K, Hamaoka-Okamoto A et al (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5:e003289CrossRef Friedman KG, Gauvreau K, Hamaoka-Okamoto A et al (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5:e003289CrossRef
34.
Zurück zum Zitat Yan F, Pan B, Sun H, Tian J, Li M (2019) Risk factors of coronary artery abnormality in children with kawasaki disease: a systematic review and meta-analysis. Front Pediatr 7:374CrossRef Yan F, Pan B, Sun H, Tian J, Li M (2019) Risk factors of coronary artery abnormality in children with kawasaki disease: a systematic review and meta-analysis. Front Pediatr 7:374CrossRef
35.
Zurück zum Zitat Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, Sonobe T, Nakamura Y (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171:651–656CrossRef Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, Sonobe T, Nakamura Y (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171:651–656CrossRef
36.
Zurück zum Zitat Suzuki T, Kakimoto N, Tsuchihashi T, Suenaga T, Takeuchi T, Shibuta S, Kitano N, Suzuki H (2021) Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan. Eur J Pediatr (Mar 24). https://doi.org/10.1007/s00431-021-04006-1 Suzuki T, Kakimoto N, Tsuchihashi T, Suenaga T, Takeuchi T, Shibuta S, Kitano N, Suzuki H (2021) Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan. Eur J Pediatr (Mar 24). https://​doi.​org/​10.​1007/​s00431-021-04006-1
Metadaten
Titel
Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country
verfasst von
Mohd Nizam Mat Bah
Emieliyuza Yusnita Alias
Hasliza Razak
Mohd Hanafi Sapian
Fang Han Foo
Nisah Abdullah
Publikationsdatum
04.06.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 8/2021
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-021-04135-7

Weitere Artikel der Ausgabe 8/2021

European Journal of Pediatrics 8/2021 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.